Test, Tubercolosis (TB) drug susceptibility

Primary use
Diagnosis / Measurement / Monitoring
Type of medical device or related product
In vitro diagnostic tests
Multiple vs. specific use (health condition)
Multiple
Intended population age
Adults (20 to 64 years)
Later adults (over 64 years)
Intended population sex
All
Level of technical knowledge
Specialized clinical
Capital
No
Reusable
No
Requirements
None
WHO list of priority medical devices
Cancer management (2017)
Cardiovascular diseases and diabetes (2021)
COVID-19 (2020)
Reproductive, maternal, newborn and child health (2015)
Service delivery platforms / Healthcare levels
Second-level and third-level hospital services and specialized outpatient services
Healthcare unit
Laboratory
EMDN related code(s)
W01040805
Manual susceptibility testing
The code(s) and term(s) in this section were observed and retrieved from public databases and have not been validated by health regulatory authorities. Please consult your regulatory agency and EMDN site: https://webgate.ec.europa.eu/dyna2/emdn
GMDN related code(s)
45367
Multiple antimycobacterial susceptibility testing kit IVD (A collection of reagents and other associated materials containing multiple susceptibility testing discs impregnated with a range of antimycobacterial agents (i.e., drugs intended for treatment and/or prevention of a mycobacterial infection) intended to be used to determine the antimicrobial susceptibility profile of a specific Mycobacterium organism, isolated from a clinical specimen by culture.)
The medical device term(s), code(s) and definition(s) in this section were retrieved from databases external to WHO. As there might be more than one name, definition and “Nomenclature Code” related to the specific medical device, please consult https://gmdnagency.org GMDN ®. © GMDN Agency 2005-2025 
WHO related resources
Decommissioning
WHO resources on medical devices